Familial Nephrocalcinosis Associated With Heterozygous SLC34A1 and TRPV5 Variants Presenting With Elevated 1,25-Dihydroxyvitamin D: Familial Nephrocalcinosis

Emre Çankaya; Faysal Gök; Vedat Gencer

doi:10.5281/zenodo.19169617

Authors

Emre Çankaya Ankara Bilkent City Hospital, Department of Nephrology, Ankara, Türkiye https://orcid.org/0000-0003-3805-6352
Faysal Gök Medicana International Ankara Hospital, Department of Pediatric Nephrology and Rheumatology, Ankara, Turkiye https://orcid.org/0000-0002-1073-3182
Vedat Gencer Department of Nephrology, Kayseri City Hospital, Kayseri, Türkiye https://orcid.org/0000-0003-1459-2708

DOI:

https://doi.org/10.5281/zenodo.19169617

Keywords:

Nephrocalcinosis, Hypercalciuria, Vitamin D, Sodium-Phosphate Cotransporter Proteins (SLC34A1)

Abstract

Nephrocalcinosis is frequently associated with inherited disturbances of calcium-phosphate metabolism and renal tubular transport. Variants affecting renal phosphate reabsorption or distal tubular calcium handling may result in hypercalciuria, nephrolithiasis, and progressive renal calcification. The SLC34A1 gene encodes the sodium-phosphate cotransporter NaPi-IIa in the proximal tubule, and loss-of-function variants can cause renal phosphate wasting with inappropriate activation of 1α-hydroxylase, leading to elevated 1,25-dihydroxyvitamin D. The TRPV5 gene encodes a calcium-selective channel in the distal nephron and is essential for transcellular calcium reabsorption. We report a familial nephrocalcinosis phenotype in a 30-year-old woman and her 2-year-old daughter. The mother presented with bilateral flank pain, dysuria, palpitations, and fatigue. Laboratory evaluation demonstrated suppressed parathyroid hormone (PTH 9.6 pg/mL), serum calcium at the upper limit of normal (9.7 mg/dL), normal phosphate (3.1 mg/dL), chronically low 25-hydroxyvitamin D (24 ng/mL), and elevated 1,25-dihydroxyvitamin D, suggesting PTH-independent calcitriol excess. Nephrocalcinosis had previously been detected in the child. Targeted next-generation sequencing revealed a heterozygous splice-region variant in SLC34A1 (NM_003052.5:c.644+5G>C) and a heterozygous missense variant in TRPV5 (NM_019841.7:c.1849G>A; p.Gly617Arg) in both individuals. This case is presented as a hypothesis-generating report. Although both variants are classified as variants of uncertain significance, the shared genotype and characteristic biochemical profile suggest a potential disturbance of renal phosphate and calcium handling that may contribute to familial nephrocalcinosis and PTH-independent elevation of active vitamin D. However, definitive causal inferences cannot be established without additional evidence including segregation analysis in extended family members, functional studies, and comprehensive biochemical characterization.

References

Hernando N, Gagnon K, Lederer E. Phosphate transport in epithelial and nonepithelial tissue. Physiol Rev. 2021;101(1):1-35.

Schlingmann KP, Ruminska J, Kaufmann M, et al. Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol. 2016;27(2):604-614.

Lenherr-Taube N, Young EJ, Furman M, et al. Mild idiopathic infantile hypercalcemia-part 1: biochemical and genetic findings. J Clin Endocrinol Metab. 2021;106(10):2915-2937.

van der Wijst J, van Goor MK, Schreuder MF, Hoenderop JG. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis. Kidney Int. 2019;96(6):1283-1291.

Brunkhorst M, Brunkhorst L, Martens H, et al. Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT2a and NPT2c. Kidney Int. 2025;107(1):116-129.

Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410-421.

Lafci NG, van Goor M, Cetinkaya S, et al. Decreased calcium permeability caused by biallelic TRPV5 mutation leads to autosomal recessive renal calcium-wasting hypercalciuria. Eur J Hum Genet. 2024;32(11):1506-1514.

Gordon RJ, Li D, Doyle D, Zaritsky J, Levine MA. Digenic heterozygous mutations in SLC34A3 and SLC34A1 cause dominant hypophosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab. 2020;105(7):2392-2400.

Familial Nephrocalcinosis Associated With Heterozygous SLC34A1 and TRPV5 Variants Presenting With Elevated 1,25-Dihydroxyvitamin D